- Home
- KROS vs QNST Comparison
KROS vs QNST Comparison
Compare KROS & QNST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | KROS | QNST |
|---|---|---|
| Founded | 2015 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Business Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 584.9M | 694.8M |
| IPO Year | 2020 | 2009 |
Fundamental Metrics
Financial Performance| Metric | KROS | QNST |
|---|---|---|
| Price | $11.49 | $13.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 4 |
| Target Price | $21.86 | ★ $24.75 |
| AVG Volume (30 Days) | 335.5K | ★ 600.3K |
| Earning Date | 05-06-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 146.00 | N/A |
| EPS | ★ 2.30 | 0.94 |
| Revenue | $243,864,000.00 | ★ $282,140,000.00 |
| Revenue This Year | N/A | $18.59 |
| Revenue Next Year | $2,751.79 | $14.80 |
| P/E Ratio | ★ $5.02 | $13.32 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $10.42 | $10.29 |
| 52 Week High | $22.55 | $19.29 |
Technical Indicators
Market Signals| Indicator | KROS | QNST |
|---|---|---|
| Relative Strength Index (RSI) | 44.36 | 58.31 |
| Support Level | $10.56 | $11.57 |
| Resistance Level | $12.65 | $15.44 |
| Average True Range (ATR) | 0.42 | 0.41 |
| MACD | 0.08 | 0.07 |
| Stochastic Oscillator | 37.50 | 68.29 |
Price Performance
Historical ComparisonAbout KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About QNST QuinStreet Inc.
QuinStreet Inc focuses on marketplaces and technologies for the financial services and home services industries. It delivers measurable and cost-effective marketing results to its clients, in the form of qualified inquiries such as clicks, leads, calls, applications, or customers. It generates revenue by delivering measurable online marketing results to the clients. Its products and services are Customer Acquisition, QuinStreet Rating Platform (QRP), and CloudControlMedia. Geographically, it operates in United States and Internationally, of which maximum revenue is derived from United States.